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We recently identified and described a putative prophage on the genomic island
FhaGI-1 located within the genome of Francisella hispaniensis AS02-814 (F. tularensis
subsp. novicida-like 3523). In this study, we constructed two variants of a
Francisella phage integration vector, called pFIV1-Val and pFIV2-Val (Francisella
Integration Vector-tRNAVal-specific), using the attL/R-sites and the site-specific integrase
(FN3523_1033) of FhaGI-1, a chloramphenicol resistance cassette and a sacB gene
for counter selection of transformants against the vector backbone. We inserted
the respective sites and genes into vector pUC57-Kana to allow for propagation in
Escherichia coli. The constructs generated a circular episomal form in E. coli which could
be used to transform Francisella spp. where FIV-Val stably integrated site specifically into
the tRNAVal gene of the genome, whereas pUC57-Kana is lost due to counter selection.
Functionality of the new vector was demonstrated by the successfully complementation
of a Francisella mutant strain. The vectors were stable in vitro and during host-cell
infection without selective pressure. Thus, the vectors can be applied as a further
genetic tool in Francisella research, expanding the present genetic tools by an integrative
element. This new element is suitable to perform long-term experiments with different
Francisella species.
Keywords: Francisella tularensis, integrative vector, pFIV-Val, genomic island, episomal, phage
INTRODUCTION
Francisella tularensis, the causative agent of tularemia, is found in a wide range of wild animals
and can infect humans, causing various clinical expressions ranging from skin lesions to severe
pneumonia, depending on the route of infection (Ellis et al., 2002). Infections in humans are
mostly associated with the highly virulent F. tularensis subsp. (Ft.) tularensis and the less virulent
subspecies Ft. holarctica (Fth) (Keim et al., 2007). Opportunistic infections by other Francisella
species such as F. hispaniensis (Fhis), F. novicida (Fno), and F. philomiragia (Fph) have been
reported in individuals with compromised immune systems (Hollis et al., 1989; Clarridge et al.,
1996; Whipp et al., 2003). Recently, a new Francisella species (Francisella sp. strain W12-1067) has
been identified in an aquatic habitat in Germany (Rydzewski et al., 2014). Yet it is not clear if the
new species will be grouped into the genus Francisella or into the new genus “Allofrancisella” (Qu
et al., 2013, 2016; Challacombe et al., 2017a). So far it is not known if this species is able to infect
humans.
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We recently identified and described the genomic island (GI)
FhaGI-1, located in the genome of Fhis AS02-814 (Ft. subsp.
novicida-like 3523) that contains a putative prophage (Schunder
et al., 2013). We could show that the GI integrates site specifically
into the tRNAVal gene of the genome and that it generates an
episomal form in an integrase-dependent manner. Furthermore,
we could demonstrate that small variants of FhaGI-1 are able
to integrate site specifically into the genome of other Francisella
species (Rydzewski et al., 2015). Therefore, we decided to create
the first Francisella phage integration vector on the basis of
this GI.
There are a number of tools to manipulate Francisella
genetically. For the expression of genes and complementation
in trans, there are several shuttle-vectors derived from the cryptic
plasmid pFNL10. Although the second and third generation of
these vectors are mostly stable without selective pressure, high
copy numbers can still pose a problem (Norqvist et al., 1996;
Pomerantsev et al., 2001; Maier et al., 2004; LoVullo et al., 2006).
Vectors based on plasmids from Fph expand the repertoire of
shuttle-vectors and make it possible to use more than one vector
per organism (Le Pihive et al., 2009). Chromosomal integration
is a way to circumvent the problems associated with high copy
numbers. For many bacteria, integration systems based on the
site-specific elements of bacteriophages have been described
(Lee et al., 1991; Hoang et al., 2000; Lauer et al., 2002). In
general, these vectors consist of the site-specific integrase of
a bacteriophage together with its attP-site (Campbell, 2003), a
resistance gene, and a multiple cloning site. For Francisella few
chromosomal integration systems have been described so far.
The existing systems are either based on allelic exchange or a
mini-Tn7 vector. Both systems produce transformants that are
stable without selective pressure, but they also require helper
plasmids or multiple rounds of transformation and selection
(Ludu et al., 2008; LoVullo et al., 2009a,b). Phage integration
vectors have not been generated for Francisella since phages for
this organism have not been described before (LoVullo et al.,
2009a; Rydzewski et al., 2015). Further cryptic plasmids and a
putative conjugative element have been described recently and
may be used to generate further plasmids for Francisella in the
future (Siddaramappa et al., 2014; Challacombe et al., 2017b).
Here we report the construction of two variants of a new phage
integration vector pFIV-Val on the basis of the genomic island
FhaGI-1 that replicate in Escherichia coli and integrate stably and
site specifically into the genome of different Francisella species.
MATERIALS AND METHODS
Strains and Growth Conditions
Strains used in this study were E. coli (DH10B) One Shot R©
TOP 10 (Invitrogen) and various Francisella strains (see Table 1).
The iglC mutant strain of Fth strain LVS was kindly provided
by Anders Sjöstedt (Golovliov et al., 2003). For genes and
abbriviations used, see Table 1.
E. coli was cultivated in Luria-Bertani (LB) medium or on
LB agar. The antibiotic concentrations used for E. coli were
chloramphenicol (Cm) 40 µgml−1 and kanamycin (Km) 40 µg
ml−1. Francisella strains were cultivated in medium T (Pavlovich
and Mishan’kin, 1987; Becker et al., 2016), on medium T-
based agar plates (MT-KH agar: medium T containing 2.4 g
l−1 of activated charcoal, 14.3 g l−1 of agar and 9.5 g l−1 of
hemoglobin), or on HCA agar (Brain Heart Infusion Agar
[Liofilchem, Roseto degli Abruzzi, Italy] with 10% sheep blood).
The antibiotic concentrations used for Francisella were 10 µg
ml−1 for chloramphenicol and 12 µgml−1 for kanamycin.
The human macrophage-like cell line U937 (ATCC CRL-
1593.2) (growth medium RPMI 1640 + 10% FCS [purchased
from PAA, Pasching, Austria]) was used to investigate the
intracellular multiplication of Francisella strains. U937 cells were
cultivated at 37◦C and 5% CO2.
Construction of Integration Vectors
Three different DNA constructs used to generate pFIV-Val
vectors were generated by in vitro DNA synthesis. DNA
synthesis and DNA sequence verification by DNA sequencing
were performed by GeneCust (Dudelang, Luxembourg). The
different constructs were then used to generate pFIV-Val vectors
1, 2, and pFIV1-iglC, using pUC57-Kana as the back-bone
(for details, see Table 1 and Figure 1). Construct 1: FhaGI-gfp-
CmR is composed of 4,644 bp, exhibiting the tRNAVal gene
of FhaGI-1 (Rydzewski et al., 2015), followed by restriction
sites for NotI, BclI, and SnaBI, a gfp gene with promotor from
vector pKK289KmGFP (Bönquist et al., 2008), restriction sites
for NotI and SacII, the GroES promotor of Fth LVS (pGroES)
(Ericsson et al., 1997), the iglA promotor with the PigR response
element (PRE, underlined bps in PRE∗), (PRE∗: AGCTGTATAA
ACATTGTGTT ATTGGCGTTA TTAAGGTAAC TT) (Ramsey
et al., 2015), the GroES promotor from strain Francisella sp.
strain W12-1067 (Rydzewski et al., 2014), followed by a Cm
resistance cassette (952 bp) with promotor GroES from vector
pKK289KmGFP (Bönquist et al., 2008), the integrase of FhaGI-
1 (FN3523_1033), and the phage integration site attR (47 bp)
(Rydzewski et al., 2015).
We introduced the PRE∗ site into the pFIV-Val vector to
introduce a promotor that should be active during intracellular
replication of Francisella. It has been published that the PRE
element is an activator sequence for the expression of virulence
genes, including genes (e.g., iglC) present on the Francisella
pathogenicity island (FPI), and that genes of the FPI are induced
during intracellular replication of Francisella (Ramsey et al.,
2015).
Construct 2: The sequence (2389 bp) of construct 2 (see
Figure 1) is identical to the sequence of FhaGI-gfp-CmR
except for the restriction sequences surrounding the gfp gene,
designated MCS1 with restriction sites for NotI, BclI, SacI, AatII,
and MCS2 with restriction sites for KpnI, EcoRV, NotI, and
NcoI. Construct 3 (in pFIV2-Val): SacB-tRNA-MCS3 (2502 bp) is
composed of the complete sacB gene (2007 bp) of Bacillus subtilis
(Steinmetz et al., 1985), the tRNAVal gene and a singular MCS3
including restriction sites for BclI, SacI, AatII, KpnI, EcoRV, NotI,
and NcoI (Figure 1). In addition, the iglC gene of Ft. holarctica
LVS (construct 4) was cloned into pFIV1-Val using SacI/NheI
leading to pFIV1-iglC (Figure 1). The maps of pFIV-Val vectors
are given in Figure S1.
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TABLE 1 | Strains and genetic elements used in this study.
Strain (abbreviation) Characteristics References
Francisella tularensis holarctica LVS (Fth LVS) Live vaccine strain ATCC 29684
Francisella tularensis holarctica LVS FIV1-Val (Fth LVS FIV1-Val) Strain containing vector FIV1-Val This work
Francisella tularensis holarctica LVS FIV1-Val gfp (Fth LVS
FIV1-Valgfp)
Strain containing vector FIV1-Val with additional gfp-gene This work
Francisella tularensis holarctica LVS FIV2-Val (Fth LVS FIV2-Val) Strain containing vector FIV2-Val This work
Francisella tularensis holarctica LVS 1iglC (Fth LVS 1iglC) iglC deletion mutant Golovliov et al., 2003
Francisella tularensis holarctica LVS 1iglC+FIV1-iglC (Fth LVS
1iglC+FIV1-iglC)
iglC deletion mutant complemented with FIV1-iglC This work
Francisella tularensis holarctica wild type Isolated from beaver carcass Schulze et al., 2016
Francisella novicida U112 (Fno U112) Wild type strain ATCC 15482
Francisella novicida U112 FIV1-Val (Fno U112 FIV1-Val) Strain containing vector FIV1-Val This work
Francisella novicida Fx1 (Fno Fx1) Wild type strain FSC 156
Francisella sp. strain W12-1067 Wild type strain Rydzewski et al., 2014
Francisella W12-1067 FIV1-Val Strain containing vector FIV1-Val This work
Francisella hispaniensis (Fhis) Wild type strain Whipp et al., 2003
Gene name/genetic construct Characteristics References
Integrase (Int) Site specific integrase of FhaGI-1 (FN3523_1033) Rydzewski et al., 2015
pGroES GroES promotor of Ft. holarctica LVS Ericsson et al., 1997
pGroES (W12) GroES promotor of strain Francisella sp. W12-1067 Rydzewski et al., 2014
PRE* iglA promotor with PigR response element (PRE) Ramsey et al., 2015
attL-site (tRNAVal) General integration site for FhaGI-1 Rydzewski et al., 2015
attB (chromosomal); attP (episomal) Phage attachment sites Campbell, 2003
attR- site Necessary for the formation of the episomal form of FhaGI-1 Rydzewski et al., 2015
sacB sacB gene from Bacillus subtilis, coding for a secreted levansucrase Steinmetz et al., 1985
CmR Chloramphenicol resistance cassette, Aeromonas hydrophila GenBank accession: AJ973195.1
KmR Kanamycin resistance cassette pUC57-Kana (GeneCust)
For the handling of pFIV-Val vectors in in E. coli it is necessary
to use chloramphenicol and kanamycin simultaneously to select
for clones containing the whole vector. Otherwise, the episomal
form, which is generated in E. coli will be lost, leading to strains
containing only the ‘empty’ vector. This is because the episomal
form (FIV-Val) is unable to integrate into the genome of E. coli
or to replicate in E. coli. For further details, see Results and
Discussion section.
DNA Techniques and PCR Analysis
Plasmid DNA for restriction digestion and PCR analysis was
prepared using the Invisorb Plasmid Mini Two Kit (Stratec,
Berlin, Germany), and preparation of genomic DNA was done
with the Blood & Tissue kit (Qiagen, Hilden, Germany).
Restriction enzymes were purchased from New England BioLabs
and used according to the manufacturer’s protocols (Frankfurt
a. M., Germany). PCR was carried out using a Thermocycler
TRIO-Thermoblock (Biometra, Göttingen, Germany) and the
TopTaq DNA polymerase (Qiagen, Hilden, Germany). Analysis
of E. coli transformants was done with primer pairs Fha-1P/Fha-
2∗∗ (for pFIV1-Val), SacB_R_out/Fha-2∗∗ (pFIV2-Val) and Fha-
3∗/Fha-4P, for the presence of the complete construct and Fha-
1P/Fha-4P (pFIV1-Val) and SacB_R_out/Fha-4P (pFIV2-Val), for
presence of the “empty” vector. The presence of the episomal
form was shown using primer pair Fha-2∗∗/Fha-3∗. Integration
of the vectors into the genome of Francisella strains was shown
using primer combinations Fha-1/Fha-2∗∗ and Fha-3∗ /Fha-
4∗ (for integration into Fth LVS and Fno U112) and Fha-
1W12/Fha-2∗∗ and Fha-3/Fha-4W12 (integration in Francisella
sp. W12-1067). All mentioned primers are given in Table 2. In
general, initial denaturation was performed at 94◦C for 3min and
final extension was performed at 72◦C for 10min. The cycling
conditions (35 cycles) were 94◦C for 30 s, 57◦C for 1min and
72◦C for 1min, and ∼ 100 ng of template DNA was used.
Oligonucleotides were obtained from Eurofins MWG Operon
(Ebersberg, Germany).
Transformation of Bacteria
Plasmid DNA was introduced into E. coli by thermal shock
(30min on ice, 30 s at 42◦C, 2min on ice) (Invitrogen). After
transformation E. coli were incubated in LB medium for 1 h
at 37◦C and then plated onto agar containing 40 µg ml−1 of
chloramphenicol and 40 µg ml−1 of kanamycin. Electroporation
of Francisella strains was performed using a Gene Pulser
system (Bio-Rad, Munich, Germany). Electroporation was
done at 2.5 kV, 600 and 25 µF. After transformation
Francisella were incubated in medium T for 4 h at 37◦C
and then plated onto MT-KH or HCA agar plates containing
10 µg ml−1 of chloramphenicol and when appropriate 5%
sucrose.
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FIGURE 1 | Construction of FhaGI-1-derived vectors and cloning. Vector maps and restriction fragments for the construction of the different vector variants are
shown. Antibiotic resistance cassettes for kanamycin (KmR) and chloramphenicol (CmR) are given in black; triangles represent tRNA-Val and attR and promotors are
shown in blue; the integrase gene is shown in red; genes inserted into the MCS are shown in green (gfp) and orange (iglC); the SacB gene is shown in pink; and the
FIV-Val part of the vectors that integrates into the genome of Francisella transformants is highlighted by a yellow line. Restriction sites used in this study are indicated.
Numbers indicate constructs (1–4) used for cloning, see also Materials and Methods section. Detailed vector maps with primer binding sites are given in Figure S1.
Testing the Stability of Vectors
To test the stability of the different vectors in Francisella
transformants, they were cultured overnight in 3ml of medium
T with Cm (5 µg ml−1). The next day 200 µl of the
overnight culture were used to inoculate 3ml of fresh medium
T without antibiotics. Bacteria were passaged in this manner
every 12 h. After 10 passages the optical density at 600 nm
(OD600) of the cultures was adjusted to 1, and cultures
were diluted and plated on HCA agar with and without
chloramphenicol to determine the number of bacteria still
containing FIV-Val. Aliquots of the adjusted cultures were
used for preparation of genomic DNA and for Western
blot analysis. PCR analysis was performed to determine the
presence of the integrated as well as the episomal form of
FIV-Val.
SDS-PAGE and Immunoblotting
GFP detection was carried out by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting. The SDS-PAGE assay was performed as described
previously (Laemmli, 1970). Equal amounts of aliquots of
Francisella strains from stability testing (20 µl) were boiled for
10min in Laemmli buffer. A total of 25 µl of the solution was
loaded onto a 12% SDS polyacrylamide gel. Western blotting
was carried out using a polyclonal anti-GFP antibody (A-
11122, Thermo Fisher Scientific, Darmstadt, Germany) diluted
in 1% milk–Tris-buffered saline (TBS) (1:1,000). A horseradish
peroxidase-conjugated goat anti-rabbit antibody was used as
secondary antibody (1:1,000). Visualization was done using ECL
Western blotting substrate (Thermo Fisher Scientific) and X-ray
film.
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TABLE 2 | Primers used in this study.
Primer Tm [
◦C] Sequence 5′ 3′ (bp) References
Fha-1 61.9 aatcactccaatagccagtactaagga (27) Rydzewski et al., 2015
Fha-1W12 58.9 cttgcttcaatgactgggttttg (23) This work
Fha-2** 60.1 attagcaatgagcttagcttgttgct (26) This work
SacB_R_out 58.9 ctacgcagacaaacaatcaacgt (23) This work
Fha-3* 59.3 ctgagaattaagccacttatatcagaat (28) Rydzewski et al., 2015
Fha-4* 63.4 gtaaaacccgttggtcaaccttatcag (27) Rydzewski et al., 2015
Fha-4W12 58.9 atccaggaatctttgtaggagct (23) This work
M13U (Fha-1P) 52.8 gtaaaacgacggccagt (17) O’shaughnessy et al., 2003
M13R (Fha-4P) 54.5 ggaaacagctatgaccatg (19) O’shaughnessy et al., 2003
iglC_U 58.4 actccgatcttactatgcagct (22) This work
iglC_R 57.3 gcgagaccattcatgtgaga (20) This work
RT-FIV-CmR-U 60.3 gaaagacggtgagctggtgata (22) This work
RT-FIV-CmR-R 60.3 gtgtagaaactgccggaaatcg (22) This work
RT-FIV-CmR-TM 64.6 catcgctctggagtgaataccacga (25) This work
Ft-fopA-F 57.9 ttgggcaaatctagcaggtca (21) Schulze et al., 2016
Ft-fopA-R 60.1 atctgtagtcaacacttgcttgaaca (26) Schulze et al., 2016
Ft-fopA-TM 64.6 FAM- aagaccaccaccaacatcccaagca-BHQ-1 (25) Schulze et al., 2016
Intracellular Replication in U937 Cells and
Fluorescence Microscopy
For differentiation into macrophage-like cells, U937 cells were
transferred into fresh RPMI medium containing 10% fetal calf
serum (10% FCS), and PMA (phorbol-12-myristate-13-acetate,
1 mg/ml in dH2O [P-8139; Sigma-Aldrich Chemie, Munich,
Germany]) was added at a concentration of 1:20,000. After
incubation for 36 h at 37◦C and 5% CO2, the supernatant was
discarded and adherent cells were washed once with 10ml of
0.2% EDTA in PBS. Cells were mechanically detached from the
flask bottom and adjusted to 5 × 105 cells/ml with RPMI + 10%
FCS. To eachwell of a 24-well plate 1ml of the cell suspensionwas
added and incubated for 2 h at 37◦C and 5% CO2 for adhesion.
Overnight cultures of Francisella strains were diluted in plain
RPMI medium, and the infection was done with a multiplicity
of infection (MOI) of 10 (time point 0 h) for 2 h at 37◦C and 5%
CO2. Cells were washed three times with RPMI and incubated
with 50 µg ml−1 of Gentamycin for 1 h to kill extracellular
bacteria. Cells were washed again three times with RPMI and
covered with 1ml of RPMI. To determine the CFU at various
time points of infection, coincubations of cells and bacteria were
lysed by addition of 10 µl of 10% Saponin (S4521, Sigma-Aldrich
Chemie) and serial dilutions were plated on HCA agar.
During the infection fluorescent images were obtained every
24 h using an inverse microscope (Carl Zeiss, Jena, Germany).
Copy Number
Copy numbers of FIV-Val were determined by qPCR-analysis. As
target for the vector the CmR gene was used and as chromosomal
reference the single copy gene fopA. Primers and hydrolysis
probes are given in Table 2.
qPCRs were conducted in a total volume of 25 µl using
the ABI 7500 Real Time PCR System and the TaqMan R©
Environmental Master Mix 2.0 (Applied Biosystems). Primers
and hydrolysis probes were used at a final concentration of
0.3mM and 0.1mM, respectively. 5 µl of target DNA were added
to each reaction. For each vector three decimal dilutions of
DNA (0.1; 0.01; 0.001 ng) were pipetted in duplicate. Reactions
were initiated with an incubation at 95◦C for 10min followed
by 40 cycles of 95◦C for 15 s (denaturation) and 60◦C for
60 s (annealing and elongation, detection). Copy numbers were
calculated using the 1Ct method.
RESULTS AND DISCUSSION
Construction of pFIV-Val
Recently, we demonstrated that the att-sites of FhaGI-1 of
Fhis AS02-814 in combination with the site-specific integrase
are sufficient to generate the episomal form FIV-Val of the
vector in E. coli and that after transformation into Fth LVS the
element integrates site specifically into the tRNA-Val gene of
transformants (Rydzewski et al., 2015). We now utilized this
information to develop phage integration vectors to be used in
Francisella research, with the idea that the constructs would be
integrated site specifically and stable into the genome.
We constructed a first variation of the vector, called pFhaGI-
gfp-CmR (7,681 bp) (Figure 1 and Figure S1A). The construct
was composed of the following elements (see also Table 1): (1)
the attL-site (tRNAVal) which is the general integration site for
FhaGI-1; (2) a gfp gene flanked by restriction sites that serves
as a place holder for the integration of future genes of interest
(at this first stage) and as a control for gene expression during
intracellular replication, (3) the Fth LVS GroES promotor; (4)
the PRE∗ site that is used for the expression of genes during
intracellular replication of Francisella in host cells; (5) the GroES
promotor of strain Francisella sp. W12-1067 (pGroES-W12)
for expression of genes in this species; (6) a chloramphenicol
resistance marker for the selection process after transformation;
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(7) the site-specific integrase which is necessary for generating the
episomal form and the integration into the attB-site (tRNAVal) of
the acceptor strain (Francisella strain of interest) and the attR-
site which is necessary for the formation of the episomal form of
pFhaGI-gfp-CmR. For details, see also Materials and Methods.
As a backbone, the plasmid pUC57-Kana was used to allow
propagation of the construct in E. coli. Note, only the FhaGI-
gfp-CmR construct (Figure 1 episomal form, marked in yellow)
will be integrated site specifically into the genome of the acceptor
strain (Rydzewski et al., 2015).
The construct was then introduced into E. coli by chemical
transformation and plated on agar containing chloramphenicol
and kanamycin. We isolated plasmid DNA from this strain and
analyzed it for the presence of all three forms of pFhaGI-gfp-
CmR using primer pairs 1P/2∗∗ and 3∗/4P (pFIV-Val), 2∗∗/3∗
(episomal form, FIV-Val), and 1P/4P (“empty” vector with attB-
site) (Figures 2A,B). The PCRs confirmed that all three forms
were present which means that the integrase is active in E. coli.
The plasmid preparation of pFhaGI-gfp-CmR was introduced
into Fth LVS by electroporation and plated onto agar plates
containing chloramphenicol. One hundred clones were picked
and then transferred to plates containing kanamycin for negative
selection against transformants still harboring the “empty”
vector. Of the picked clones∼30%were kanamycin sensitive and,
therefore, maintained only the desired construct (FhaGI-gfp-
CmR), the episomal or genomically integrated form of pFhaGI-
gfp-CmR (Figure 2A). The loss of the “empty” pUC57-Kana
vector was also confirmed by PCR analysis (Figure 2C, lane
5). To test these clones for site-specific integration into the
tRNAVal gene they were further analyzed by PCR using species
specific (acceptor strain) primers (Figure 2C and Table 2). PCR
confirmed that the construct was successfully integrated into the
genome of Fth LVS (Figure 2C, lanes 1 and 3) and that the
episomal form was also present (Figure 2C, lane 2). In addition,
the PCR product of about 500 bp using primers 1/4∗ (Figure 2C,
lane 4) confirmed that after excision of FIV-Val, no copy of the GI
is left in the genome (see also Rydzewski et al., 2015), indicating
that the episomal form is not generated in a replicative way.
The results demonstrated that the concept of a phage integration
vector works at least in Fth.
Subsequently we optimized our vector by introducing anMCS
on both sites of the gfp gene resulting in vector pFIV1-Val (7,706
bp) (Figure 1 and Figure S1B).
Functional Characterization of pFIV1-Val
An important characteristic of a vector is its stability without a
selective pressure. To test the stability of FIV1-Val in Fth LVS
without any selective pressure, we cultivated Fth LVS harboring
FIV1-Val in medium T without antibiotics. After 10 passages, we
plated cultures on HCA agar with and without chloramphenicol.
As shown in Figure 3A, the CFU of tested strains on agar plates
containing chloramphenicol was similar to that on agar without
antibiotics, demonstrating that FIV1-Val remained stable without
selective pressure. This was further verified by PCR analysis
which confirmed the presence of the integrated as well as the
episomal form of FIV1-Val (Figure 3B). To test if the gene
FIGURE 2 | Forms of pFhaGI-1-gfp-CmR. (A) In E. coli transformants three forms of the vector are present: the complete construct (pFhaGI-gfp-CmR, representing
pFIV-Val), the “empty” pUC57-Kana vector with attB-site, and the episomal form with attP-site (FhaGI-gfp-CmR, representing FIV-Val). After transformation into
Francisella the FIV-Val part integrates site specifically into the genome. Arrows indicate primers used to detect the different forms of pFhaGI-1-gfp-CmR. (B) PCR
analysis of an E. coli transformant containing pFhaGI-1-gfp-CmR. (C) PCR analysis of Ft. holarctica LVS transformant containing FhaGI-1-gfp-CmR. Primers Fha-2/3
(Fha-2**/Fha-3*) show the presence of the episomal form, primers 1/2 and 3/4 (Fha-1/Fha-2** and Fha-3*/Fha-4* or Fha-1P/Fha-2** and Fha-3*/Fha-4P) show the
chromosomally integrated form of FhaGI-gfp-CmR, whereas primers 1/4 (Fha-1/Fha-4* or Fha-1P/Fha-4P) show the chromosomal attB-site.
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FIGURE 3 | Stability of FhaGI-1-based vectors. Strains Fth LVS FIV1-Val, Fth LVS FIV2-Val, Fno U112 FIV1-Val, and Francisella sp. W12-1067 FIV1-Val were
passaged 10 times in mediumT without antibiotics. (A) CFU of strains on HCA agar and HCA agar containing Chloramphenicol (10 µg ml−1 ) after 10 passages in
mediumT without antibiotics; results shown are means with SD of three independent experiments. (B) PCR analysis of genomic DNA of strains after 10 passages
without antibiotics. Primers 2/3 (Fha-2**/Fha-3*) show the presence of the episomal form, primers 1/2 and 3/4 (Fha-1 or Fha-1W12/Fha-2** and Fha-3*/Fha-4* or
Fha-4W12) show the chromosomally integrated form of FIV-Val, and primers 1/4 (Fha-1/Fha-4* or Fha-1W12/Fha-4W12 ) show the chromosomal attB-site. (C) Western
Blot analysis of whole cell lysates with rabbit-α-gfp antibody (1:1,000).
of interest (e.g., gfp) cloned into pFIV1-Val was expressed in
the acceptor strain, Western Blot analysis using an anti-GFP
antibody was performed. The results demonstrated that the gfp
gene was expressed (Figure 3C, lane 1), indicating that the used
promotor element of FIV-Val is active in Fth. The wild type
control proves that although the observed band is rather faint it
is not due to background binding of the antibody in the strain
(Figure 3C, lane 2).
To demonstrate further that the integration vector is
functional in Francisella, we used it to complement a specific
mutant strain of Fth. We chose an iglC mutant strain of Fth
LVS which is known to be unable to replicate within host cells
(Golovliov et al., 2003). We cloned the iglC gene into pFIV1-
Val, resulting in pFIV1-iglC (Figure 1). FIV1-iglC was then
successfully integrated into the iglC mutant strain, leading to
strain Fth LVS 1iglC+FIV1-iglC. The site-specific integration of
the construct was confirmed by PCR analysis (data not shown).
Then we performed infection assays with this strain as well as
the Fth LVS wild-type strain and Fth LVS FIV1-Val, using the
humanmacrophage-like cell line U937 (Figure 4A). As expected,
the Fth LVS wild-type strain replicated in the macrophages
while the iglC mutant strain did not. The complemented iglC
mutant strain was able to replicate in U937 cells nearly as
well as the wild-type strain (Figure 4A). The nearly complete
complementation of the iglCmutant might be due to the fact that
both copies of the iglC gene present in the wild-type strain had
been inactivated (Golovliov et al., 2003; Lai et al., 2004) and that
the expression of the gene from FIV1-Val was not high enough
to complement both inactivated genes. However, the intracellular
growth defect of the iglC mutant strain was complemented. In
addition, we could demonstrate that the presence of FIV1-Val
alone did not influence the intracellular replication of Fth LVS
(Figure 4A). The results demonstrated that FIV-Val was stable
without selective pressure and could be used to express genes
of interest during intracellular replication of Francisella in host
cells. In addition, since FIV-Val did not influence the ability
of Francisella to replicate intracellularly in host cells, pFIV-Val
can be used for successful complementation of specific mutant
strains.
In a further infection assay, we verified whether we could
visualize the expression of the gfp gene during intracellular
replication of Francisella. Activity of the gfp gene of FIV1-
Val during the infection of U937 cells was visualized using a
fluorescence microscope. As shown in Figure 4B, the activity of
the GFP was low but macrophages containing fluorescent Fth
LVS FIV1-Val could be demonstrated after 48 h and the number
of fluorescent cells increased after 72 h. The results corroborated
that the gene of interest cloned into pFIV-Val is expressed
during intracellular replication. LoVullo and colleagues observed
a similarly low number of fluorescent cells when using a Tn7-
based chromosomal integration system to insert a gfp gene into
the genome of Fth LVS (LoVullo et al., 2009a). They attributed the
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FIGURE 4 | Infection assays using a human macrophage-like cell line (U937). (A) Replication of Fth LVS wild type (LVS), Fth LVS iglC mutant (LVS 1iglC),
complemented Fth LVS iglC mutant (LVS 1iglC+FIV1-iglC) and Fth LVS wild type containing FIV1-Val (LVS FIV1-Val). Cells were infected at an MOI of 10, and CFU
was determined by plating on HCA agar every 24 h. Results are mean standard deviations of duplicate samples and are representative of at least 3 independent
experiments. *, done only twice. (B) Fluorescence microscopy of U937 cells infected with Fth LVS FIV1-Val or Fth LVS FIV1-Valgfp. f, fluorescence; b, bright field; m,
merge.
poor visualization to a multitude of factors including promotor
strength and improper folding of the GFP. Another factor that
might account for the rather weak fluorescent signal could be a
low copy number of the gene. Experiments using a strain with an
additional gfp gene cloned into pFIV1-Val (pFIV-Valgfp) seemed
to support the theory of low copy numbers. With this strain a
fluorescent signal was visible after 24 h and overall there seemed
to be more fluorescent cells (Figure 4B, lane LVS FIV1-Valgfp).
Altogether these results further confirmed that FIV1-Val remains
stable in Fth without selective pressure and that it can be used to
manipulate Fth strains genetically.
Functionality Test of pFIV-Val in Other
Francisella Species
To validate whether pFIV-Val could also be used in other
Francisella species, we transformed Fno U112, Fno Fx1, and
Francisella sp. W12-1067 with pFIV-Val. For all three strains
we verified the site-specific integration into the genome and
the presence of the episomal form by PCR analysis (Figure 3B).
We further analyzed Fno U112 and Francisella sp. W12-1067
for the stability of FIV1-Val (Figure 3A). In both species the
construct remained stable integrated after 10 passages in medium
T without antibiotics (Figure 3B, lanes U112 FIV1 and W12
FIV1, respectively). GFP activity in both strains was low but
could be confirmed by Western-Blot analysis (Figure 3C, lanes
3 and 5). In Francisella sp. W12-1067 the amount of the GFP
protein was higher than in both other species investigated,
suggesting that the cloned promotor element is highly active
in this Francisella species. However, the differences in GFP
activity could be due to differences in vector copy number,
expression or in protein stability (improper folding, LoVullo
et al., 2009a). In our hands, similar results were also obtained
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with plasmids harboring a pGroES-gfp gene (unpublished
results).
We also successfully introduced pFIV-Val into a wild-type
strain of Fth (isolated from a beaver, Schulze et al., 2016) (data
not shown). These results show that pFIV1-Val is suitable as an
integration vector in different species and strains of Francisella.
Further Improvements and Determination
of the Copy Number of pFIV-Val
To simplify selection of FIV-Val-positive clones after
transformation, we decided to employ the idea of a negative
selection step and introduced the sacB gene of Bacillus subtilis
into that part of pFIV1-Val which does not integrate into the
genome of transformants. The sacB gene codes for a secreted
levansucrase which is toxic for Gram-negative bacteria when
expressed in the presence of sucrose (Steinmetz et al., 1983,
1985). Using the levansucrase, only one selection step of
transformants is needed since clones still harboring the “empty”
or complete vector will die in the presence of sucrose. The
construct “SacB-tRNA-MCS3” was cloned into pFIV1-Val,
leading to the second vector called pFIV2-Val (9,014 bp). In
addition, to generate a standard cloning vector pFIV2-Val,
the gfp gene has been deleted and a singular MCS 3 has been
introduced instead (Figure 1 and Figure S1D).
After transformation of pFIV2-Val into Fth LVS and selection
on agar plates containing chloramphenicol and sucrose, only
FIV2-Val-positive clones with the integrated form of FIV2-Val
could be detected by PCR analysis (Figure 3B and data not
shown). This demonstrates that the selection on sucrose was very
efficient, thus eliminating the need for a second selection step.
FIV2-Val was tested for its stability as described for FIV1-Val. The
vector remained stable without selective pressure (Figure 3B,
lanes LVS FIV2). However, since the integrase is still located
on the FIV2-Val part of the vector, the episomal (excised) form
of FIV-Val is still generated and detectable (Figure 3B, primers
2/3). Earlier we could show that the integrase is sufficient for the
excision of a small variant of FhaGI-1, but excision still occurred
in Fth LVS of an element missing the site-specific integrase. This
may be due to the presence of further integrases or RecA in the
genome sequence of the acceptor strain (Lesic and Carniel, 2005;
Rydzewski et al., 2015). We obtained a comparable result for a
genomic island (LpcGI-2) of Legionella pneumophila in which a
similar mechanism was used for the excision of the GI from the
genome (Lautner et al., 2013).
First qPCR analyses to quantify the copy number of the FIV-
Val constructs (see section Materials and Methods) suggest that
the copy number of FIV-Val in Fth LVS was 3.6 for both FIV1-
Val and FIV2-Val (see Table S1). The results demonstrated that
FIV-Val behaves in Francisella like a low-copy vector.
CONCLUSION
In this study we constructed two variants of a new phage
integration vector (pFIV1-Val and pFIV2-Val), derived from
FhaGI-1 of Fhis AS02-814 for the use in different Francisella
species. Both constructs integrate site specifically into the genome
of the acceptor species at the attB-site localized within the
tRNAVal gene and remain stable without selective pressure. The
introduction of a levansucrase into pFIV2-Val simplified the
selection process of FIV-Val-positive strains after transformation
of the acceptor with pFIV-Val. qPCR analysis suggests that there
are about 3.6 copies of FIV-Val in Fth LVS. We used pFIV1-Val
to complement successfully an iglCmutant strain of Fth LVS and
could demonstrate that an introduced ‘gene of interest’ (gfp gene)
was active in three different Francisella species.
GFP activity was not high in Fth, but the advantage of
pFIV-Val is the site-specific integration, the low copy number
and the stability without any selective pressure. In contrast
to other plasmids or integration systems, pFIV-Val can be
used without the help of “helper-plasmids” and in combination
with other expression vectors, since no origin of replication
is present on FIV-Val. Furthermore, pFIV-Val is usable in
different Francisella strains of Fth and Fno and also different
Francisella species. Thus, our results demonstrate that FhaGI-
1-derived vectors can be used as a further genetic tool in
Francisella research. With this new integration vector we now
are able to perform research (in the laboratory) on persistence
and reservoir research with Francisella spp. in long-term
experiments.
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Figure S1 | Detailed vector maps of FhaGI-derived vectors. Given are vector
maps for the different versions of the vector. Antibiotic resistance cassettes for
kanamycin (KmR) and chloramphenicol (CmR) are given in green; yellow triangles
represent tRNA-Val and attR and promotors are shown in blue; the integrase gene
is shown in red; the MCS is given in orange and the SacB gene is shown in pink;
the FIV part of the vectors that integrates into the genome of Francisella
transformants is highlighted by a yellow line; primer binding sites are indicated by
blue arrows; and restriction sites of the MCS and others used in this study are
indicated. Primer binding positions are given in the table below each map;
restriction enzymes that do not cut the vectors are given in a list below each
vector version. (A) Vector map of pFhaGI-gfp-CmR, (B) vector map of pFIV1-Val,
(C) restriction digestion of the three pFIV-Val vectors with NheI/SacI. ∗, desired
fragment; ◦, episomal form; [], empty vector; x, cut-out fragment, and (D) vector
map of pFIV2-Val.
Table S1 | Data of qPCR analysis determining the copy number of FIV-Val.
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